Structural	O
and	O
functional	O
characterization	O
of	O
the	O
human	B-DNA
CD36	I-DNA
gene	I-DNA
promoter	I-DNA
:	O
identification	O
of	O
a	O
proximal	O
PEBP2/CBF	B-DNA
site	I-DNA
.	O

CD36	B-protein
is	O
a	O
cell	O
surface	O
glycoprotein	B-protein
composed	O
of	O
a	O
single	O
polypeptide	O
chain	O
,	O
which	O
interacts	O
with	O
thrombospondin	B-protein
,	O
collagens	B-protein
type	I-protein
I	I-protein
and	I-protein
IV	I-protein
,	O
oxidized	O
low	B-protein
density	I-protein
lipoprotein	I-protein
,	O
fatty	O
acids	O
,	O
anionic	O
phospholipids	O
,	O
and	O
erythrocytes	B-cell_type
parasitized	O
with	O
Plasmodium	O
falciparum	O
.	O

Its	O
expression	O
is	O
restricted	O
to	O
a	O
few	O
cell	O
types	O
,	O
including	O
monocyte/macrophages	B-cell_type
.	O

In	O
these	O
cells	O
,	O
CD36	B-protein
is	O
involved	O
in	O
phagocytosis	O
of	O
apoptotic	B-cell_type
cells	I-cell_type
,	O
and	O
foam	O
cell	O
formation	O
by	O
uptake	O
of	O
oxidized	B-protein
low	I-protein
density	I-protein
lipoprotein	I-protein
.	O

To	O
study	O
the	O
molecular	O
mechanisms	O
that	O
control	O
the	O
transcription	O
of	O
the	O
CD36	B-protein
gene	O
in	O
monocytic	O
cells	O
we	O
have	O
isolated	O
and	O
analyzed	O
the	O
CD36	B-DNA
promoter	I-DNA
.	O

Transient	O
expression	O
experiments	O
of	O
5'-deletion	B-DNA
fragments	I-DNA
of	O
the	O
CD36	B-DNA
promoter	I-DNA
coupled	O
to	O
luciferase	B-protein
demonstrated	O
that	O
as	O
few	O
as	O
158	B-DNA
base	I-DNA
pairs	I-DNA
upstream	I-DNA
from	O
the	O
transcription	B-DNA
initiation	I-DNA
site	I-DNA
were	O
sufficient	O
to	O
direct	O
the	O
monocyte-specific	O
transcription	O
of	O
the	O
reporter	B-DNA
gene	I-DNA
.	O

Within	O
the	O
above	O
region	O
,	O
the	O
fragment	O
spanning	O
nucleotides	B-DNA
-158	I-DNA
to	I-DNA
-90	I-DNA
was	O
required	O
for	O
optimal	O
transcription	O
in	O
monocytic	B-cell_type
cells	I-cell_type
.	O

Biochemical	O
analysis	O
of	O
the	O
region	O
-158/-90	B-DNA
revealed	O
a	O
binding	O
site	O
for	O
transcription	B-protein
factors	I-protein
of	O
the	O
polyomavirus	B-protein
enhancer-binding	I-protein
protein	I-protein
2/core-binding	I-protein
factor	I-protein
(	I-protein
PEBP2/CBF	I-protein
)	I-protein
family	I-protein
at	O
position	B-DNA
-103	I-DNA
.	O

Disruption	O
of	O
the	O
PEBP2/CBF	B-DNA
site	I-DNA
markedly	O
diminished	O
the	O
role	O
of	O
the	O
PEBP2/CBF	B-protein
factors	I-protein
in	O
the	O
constitutive	O
transcription	O
of	O
the	O
CD36	B-DNA
gene	I-DNA
.	O

The	O
involvement	O
of	O
members	O
of	O
the	O
PEBP2/CBF	B-protein
family	I-protein
in	O
chromosome	O
translocations	O
associated	O
with	O
acute	O
myeloid	O
leukemia	O
,	O
and	O
in	O
the	O
transcriptional	O
regulation	O
of	O
the	O
myeloid-specific	B-DNA
genes	I-DNA
encoding	O
for	O
myeloperoxidase	B-protein
,	O
elastase	B-protein
,	O
and	O
the	O
colony-stimulating	B-protein
factor	I-protein
receptor	I-protein
,	O
highlights	O
the	O
relevance	O
of	O
the	O
regulation	O
of	O
the	O
CD36	B-DNA
gene	I-DNA
promoter	I-DNA
in	O
monocytic	B-cell_type
cells	I-cell_type
by	O
members	O
of	O
the	O
PEBP2/CBF	B-protein
family	I-protein
.	O

THs	NULL
JourNaL	NULL
or	NULL
BroLocicaL	NULL
CHEMISTRY	NULL
©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

271	NULL
,	NULL
No	NULL
.	NULL

13	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
29	NULL
,	NULL
pp	NULL
.	NULL

7781-7787	NULL
,	NULL
1996	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Structural	NULL
and	NULL
Functional	NULL
Characterization	NULL
of	NULL
the	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
IDENTIFICATION	NULL
OF	NULL
A	NULL
PROXIMAL	NULL
PEBP2/CBEF	NULL
SITE*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
October	NULL
19	NULL
,	NULL
1995	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
17	NULL
,	NULL
1996	NULL
)	NULL
Angel	NULL
L.	NULL
Armesillat§	NULL
,	NULL
Dominica	NULL
Calvo	NULL
#	NULL
§	NULL
,	NULL
and	NULL
Miguel	NULL
A.	NULL
Vega	NULL
From	NULL
the	NULL
{	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
C/Diego	NULL
de	NULL
Leon	NULL
62	NULL
,	NULL
Madrid	NULL
28006	NULL
,	NULL
Spain	NULL
and	NULL
(	NULL
Instituto	NULL
de	NULL
Parasitologia	NULL
y	NULL
Biomedicina	NULL
Lopez-Neyra	NULL
,	NULL
Consejo	NULL
Superior	NULL
de	NULL
Investigaciones	NULL
Cientificas	NULL
,	NULL
C/Ventanilla	NULL
11	NULL
,	NULL
Granada	NULL
18001	NULL
,	NULL
Spain	NULL
CD36	NULL
is	NULL
a	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
composed	NULL
of	NULL
a	NULL
single	NULL
polypeptide	NULL
chain	NULL
,	NULL
which	NULL
interacts	NULL
with	NULL
throm-bospondin	NULL
,	NULL
collagens	NULL
type	NULL
I	NULL
and	NULL
IV	NULL
,	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
,	NULL
fatty	NULL
acids	NULL
,	NULL
anionic	NULL
phospholipids	NULL
,	NULL
and	NULL
erythrocytes	NULL
parasitized	NULL
with	NULL
Plasmodium	NULL
falciparum	NULL
.	NULL

Its	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
few	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
monocyte/macrophages	NULL
.	NULL

In	NULL
these	NULL
cells	NULL
,	NULL
CD36	NULL
is	NULL
involved	NULL
in	NULL
phagocytosis	NULL
of	NULL
apoptotic	NULL
cells	NULL
,	NULL
and	NULL
foam	NULL
cell	NULL
formation	NULL
by	NULL
uptake	NULL
of	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
.	NULL

To	NULL
study	NULL
the	NULL
molecular	NULL
mechanisms	NULL
that	NULL
control	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
monocytic	NULL
cells	NULL
we	NULL
have	NULL
isolated	NULL
and	NULL
analyzed	NULL
the	NULL
CD36	NULL
promoter	NULL
.	NULL

Transient	NULL
expression	NULL
experiments	NULL
of	NULL
5'-deletion	NULL
fragments	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
coupled	NULL
to	NULL
luciferase	NULL
demonstrated	NULL
that	NULL
as	NULL
few	NULL
as	NULL
158	NULL
base	NULL
pairs	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
were	NULL
sufficient	NULL
to	NULL
direct	NULL
the	NULL
monocyte-specific	NULL
transcription	NULL
of	NULL
the	NULL
reporter	NULL
gene	NULL
.	NULL

Within	NULL
the	NULL
above	NULL
region	NULL
,	NULL
the	NULL
fragment	NULL
spanning	NULL
nucleotides	NULL
-158	NULL
to	NULL
-90	NULL
was	NULL
required	NULL
for	NULL
optimal	NULL
transcription	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Biochemical	NULL
analysis	NULL
of	NULL
the	NULL
region	NULL
-158/-90	NULL
revealed	NULL
a	NULL
binding	NULL
site	NULL
for	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
polyomavirus	NULL
enhancer-binding	NULL
protein	NULL
2/core-binding	NULL
factor	NULL
(	NULL
PEBP2/CBEF	NULL
)	NULL
family	NULL
at	NULL
position	NULL
-103	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
PEBP2/CBF	NULL
site	NULL
markedly	NULL
diminished	NULL
the	NULL
CD36	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
an	NULL
essential	NULL
role	NULL
of	NULL
the	NULL
PEBP2/CBEF	NULL
factors	NULL
in	NULL
the	NULL
constitutive	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
members	NULL
of	NULL
the	NULL
PEBP2/CBEF	NULL
family	NULL
in	NULL
chromosome	NULL
translocations	NULL
associated	NULL
with	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
,	NULL
and	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
myeloid-specific	NULL
genes	NULL
encoding	NULL
for	NULL
myeloperoxidase	NULL
,	NULL
elastase	NULL
,	NULL
and	NULL
the	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
,	NULL
highlights	NULL
the	NULL
relevance	NULL
of	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
promoter	NULL
in	NULL
monocytic	NULL
cells	NULL
by	NULL
members	NULL
of	NULL
the	NULL
PEBP2/CBF	NULL
family	NULL
.	NULL

CD36	NULL
is	NULL
a	NULL
plasma	NULL
membrane	NULL
glycoprotein	NULL
constituted	NULL
by	NULL
a	NULL
single	NULL
88-kDa	NULL
polypeptide	NULL
chain	NULL
(	NULL
Greenwalt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
which	NULL
includes	NULL
CLA-1	NULL
and	NULL
LIMPII	NULL
(	NULL
Vega	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Calvo	NULL
and	NULL
Vega	NULL
,	NULL
1993	NULL
;	NULL
Calvo	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
)	NULL
.	NULL

CD36	NULL
binds	NULL
to	NULL
a	NULL
large	NULL
variety	NULL
of	NULL
ligands	NULL
:	NULL
throm-bospondin	NULL
(	NULL
Ash	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1987	NULL
;	NULL
Silverstein	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
collagens	NULL
type	NULL
I	NULL
(	NULL
Tandon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
IV	NULL
(	NULL
Ash	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
fatty	NULL
acids	NULL
*This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Comunidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
Grant	NULL
CO86/91	NULL
and	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
y	NULL
Ciencia	NULL
of	NULL
Spain	NULL
Grants	NULL
PM91/0138	NULL
and	NULL
PB93/1020	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
17834	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Recipient	NULL
of	NULL
a	NULL
predoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
Ministerio	NULL
de	NULL
Educacion	NULL
y	NULL
Ciencia	NULL
of	NULL
Spain	NULL
and	NULL
from	NULL
the	NULL
Comunidad	NULL
Auténoma	NULL
de	NULL
Madrid	NULL
.	NULL

«	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Fax	NULL
:	NULL
34-58-203323	NULL
;	NULL
E-mail	NULL
:	NULL
mavega	NULL
@	NULL
samba.cnb.uam.es	NULL
.	NULL

(	NULL
Abumrad	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
(	NULL
Endemann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
anionic	NULL
phospholipids	NULL
(	NULL
Rigotti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
and	NULL
Plasmodium	NULL
faleiparum-infected	NULL
erythrocytes	NULL
(	NULL
Barnwell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Oquendo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

CD36	NULL
is	NULL
present	NULL
on	NULL
monocyte/	NULL
macrophages	NULL
,	NULL
platelets	NULL
,	NULL
microvascular	NULL
endothelium	NULL
,	NULL
adipo-cytes	NULL
,	NULL
mammary	NULL
epithelial	NULL
cells	NULL
,	NULL
and	NULL
erythroblasts	NULL
(	NULL
Barnwell	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Oquendo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Kieffer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Greenwalt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
van	NULL
Schravendijk	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Swerlick	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Abumrad	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Greenwalt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
its	NULL
broad	NULL
ligand-binding	NULL
specificity	NULL
,	NULL
CD36	NULL
is	NULL
considered	NULL
as	NULL
a	NULL
scavenger	NULL
receptor	NULL
(	NULL
Endemann	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Acton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Nicholson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Scavenger	NULL
receptors	NULL
are	NULL
primarily	NULL
expressed	NULL
on	NULL
macrophages	NULL
and	NULL
participate	NULL
in	NULL
cell	NULL
clearance	NULL
of	NULL
damaged	NULL
cellular	NULL
components	NULL
and	NULL
cells	NULL
and	NULL
foreign	NULL
substances	NULL
such	NULL
as	NULL
chemical	NULL
compounds	NULL
and	NULL
pathogens	NULL
(	NULL
Krieger	NULL
and	NULL
Herz	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
CD36	NULL
expressed	NULL
in	NULL
monocyte/macrophage	NULL
cells	NULL
cooperates	NULL
with	NULL
the	NULL
a	NULL
,	NULL
f	NULL
;	NULL
vitronec-tin	NULL
receptor	NULL
in	NULL
the	NULL
recognition	NULL
and	NULL
subsequent	NULL
phagocytic	NULL
clearance	NULL
of	NULL
apoptotic	NULL
cells	NULL
(	NULL
including	NULL
neutrophils	NULL
,	NULL
T	NULL
lympho-cytes	NULL
,	NULL
and	NULL
eosinophils	NULL
)	NULL
migrated	NULL
to	NULL
inflamed	NULL
areas	NULL
(	NULL
Savill	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ren	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
CD36	NULL
expressed	NULL
on	NULL
macrophages	NULL
infiltrated	NULL
in	NULL
damaged	NULL
endothelium	NULL
participates	NULL
in	NULL
the	NULL
macrophage	NULL
uptake	NULL
of	NULL
locally	NULL
formed	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
,	NULL
thus	NULL
contributing	NULL
to	NULL
foam	NULL
cell	NULL
formation	NULL
and	NULL
atherosclerosis	NULL
development	NULL
(	NULL
Endemann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Nicholson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
regulation	NULL
of	NULL
CD36	NULL
expression	NULL
in	NULL
monocytes	NULL
may	NULL
be	NULL
a	NULL
complex	NULL
process	NULL
resulting	NULL
from	NULL
the	NULL
coordinated	NULL
interplay	NULL
between	NULL
multiple	NULL
soluble	NULL
factors	NULL
and	NULL
cell	NULL
surface	NULL
adhesion	NULL
mole-cules	NULL
.	NULL

Thus	NULL
,	NULL
CD36	NULL
expression	NULL
is	NULL
dramatically	NULL
increased	NULL
on	NULL
monocytes	NULL
upon	NULL
their	NULL
interaction	NULL
with	NULL
activated	NULL
endothelium	NULL
and	NULL
by	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
or	NULL
interleukin-4	NULL
(	NULL
Huh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
CD36	NULL
expression	NULL
varies	NULL
in	NULL
some	NULL
myeloproliferative	NULL
disorders	NULL
(	NULL
Clezardin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
and	NULL
is	NULL
induced	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
promonocytes	NULL
to	NULL
monocytes	NULL
and	NULL
macrophages	NULL
(	NULL
Edelman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Up-regulation	NULL
of	NULL
CD36	NULL
may	NULL
increase	NULL
macrophage	NULL
clearance	NULL
of	NULL
apoptotic	NULL
cells	NULL
and	NULL
facilitate	NULL
monocyte	NULL
migration	NULL
through	NULL
the	NULL
endothelial	NULL
barrier	NULL
,	NULL
enhancing	NULL
oxidized	NULL
low	NULL
density	NULL
lipoprotein	NULL
uptake	NULL
and	NULL
monocyte-extracellular	NULL
matrix	NULL
in-teractions	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
treatment	NULL
with	NULL
lipopolysaccharide	NULL
or	NULL
y-interferon	NULL
results	NULL
in	NULL
down-regulation	NULL
of	NULL
CD36	NULL
mRNA	NULL
(	NULL
Huh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
data	NULL
regarding	NULL
CD36	NULL
expression	NULL
,	NULL
little	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
mechanisms	NULL
underlying	NULL
its	NULL
transcriptional	NULL
regulation	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
delineated	NULL
the	NULL
structural	NULL
organization	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
,	NULL
which	NULL
revealed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
TATA	NULL
box	NULL
located	NULL
28	NULL
base	NULL
pairs	NULL
upstream	NULL
from	NULL
the	NULL
transcription	NULL
initiation	NULL
site	NULL
(	NULL
Armesilla	NULL
and	NULL
Vega	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

To	NULL
define	NULL
the	NULL
CD36	NULL
gene	NULL
regions	NULL
,	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
transcription	NULL
factors	NULL
important	NULL
for	NULL
the	NULL
ex	NULL
7781	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
7782	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
pression	NULL
of	NULL
CD36	NULL
in	NULL
monocyte/macrophage	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
and	NULL
characterized	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
CD36	NULL
gene	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
is	NULL
mainly	NULL
controlled	NULL
by	NULL
its	NULL
proximal	NULL
promoter	NULL
region	NULL
and	NULL
that	NULL
transcription	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
polyomavirus	NULL
enhancer-binding	NULL
protein	NULL
2/core-binding	NULL
factor	NULL
(	NULL
PEBP2Z/CBEF	NULL
)	NULL
'	NULL
family	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture	NULL
and	NULL
Transient	NULL
Transfections-The	NULL
cell	NULL
lines	NULL
used	NULL
in	NULL
this	NULL
study	NULL
,	NULL
U937	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
and	NULL
THP-1	NULL
(	NULL
monocytic	NULL
)	NULL
,	NULL
Jurkat	NULL
(	NULL
T	NULL
cell	NULL
leu-kemia	NULL
)	NULL
,	NULL
K562	NULL
(	NULL
erytholeukemic	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
JY	NULL
(	NULL
B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
)	NULL
,	NULL
and	NULL
Hela	NULL
(	NULL
epitheloid	NULL
carcinoma	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
L-glutamine	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
blood	NULL
obtained	NULL
from	NULL
healthy	NULL
volunteer	NULL
donors	NULL
by	NULL
centrifugation	NULL
on	NULL
Ficoll-Hypaque	NULL
and	NULL
subsequent	NULL
adhesion	NULL
to	NULL
tissue	NULL
culture	NULL
dishes	NULL
.	NULL

U937	NULL
,	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
K562	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
.	NULL

20	NULL
x	NULL
10°	NULL
U937	NULL
or	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
500	NULL
ul	NULL
of	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

Electroporation	NULL
parameters	NULL
were	NULL
set	NULL
at	NULL
2950	NULL
microfarads	NULL
,	NULL
100	NULL
V	NULL
,	NULL
and	NULL
a	NULL
resistance	NULL
of	NULL
186	NULL
ohms	NULL
.	NULL

20	NULL
x	NULL
10°	NULL
K562	NULL
cells	NULL
were	NULL
electroporated	NULL
like	NULL
U937	NULL
cells	NULL
with	NULL
the	NULL
electric	NULL
parameters	NULL
set	NULL
up	NULL
to	NULL
400	NULL
V	NULL
,	NULL
600	NULL
microfarads	NULL
,	NULL
and	NULL
13	NULL
ohms	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
electroporated	NULL
in	NULL
250	NULL
Ll	NULL
of	NULL
OPTI-MEM	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
with	NULL
the	NULL
following	NULL
electroporation	NULL
parameters	NULL
:	NULL
1700	NULL
microfarads	NULL
,	NULL
126	NULL
V	NULL
,	NULL
and	NULL
a	NULL
resistance	NULL
of	NULL
72	NULL
ohms	NULL
.	NULL

For	NULL
all	NULL
electroporation	NULL
experiments	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
a	NULL
4	NULL
°C	NULL
for	NULL
20	NULL
min	NULL
prior	NULL
to	NULL
and	NULL
after	NULL
the	NULL
electric	NULL
shock	NULL
.	NULL

For	NULL
each	NULL
electroporation	NULL
experiment	NULL
40	NULL
pg	NULL
of	NULL
the	NULL
luciferase-reporter	NULL
vector	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
the	NULL
B-galactosidase	NULL
reference	NULL
plasmid	NULL
pCMV-Bgal	NULL
were	NULL
used	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
lipofection	NULL
as	NULL
follows	NULL
.	NULL

5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
60-mm	NULL
tissue	NULL
culture	NULL
plates	NULL
with	NULL
3	NULL
ml	NULL
of	NULL
OPTI-MEM	NULL
medium	NULL
containing	NULL
15	NULL
ug	NULL
of	NULL
Lipofectin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
luciferase	NULL
reporter	NULL
vector	NULL
,	NULL
and	NULL
1.5	NULL
ug	NULL
of	NULL
pCMV-Bgal	NULL
vector	NULL
.	NULL

After	NULL
16	NULL
h	NULL
,	NULL
the	NULL
transfection	NULL
mixture	NULL
was	NULL
replaced	NULL
by	NULL
culture	NULL
medium	NULL
,	NULL
where	NULL
cells	NULL
were	NULL
maintained	NULL
for	NULL
36-48	NULL
h.	NULL
Luciferase	NULL
and	NULL
-galactosidase	NULL
activities	NULL
were	NULL
measured	NULL
15	NULL
h	NULL
after	NULL
transfection	NULL
for	NULL
all	NULL
cells	NULL
except	NULL
Hela	NULL
,	NULL
according	NULL
to	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
and	NULL
Promega	NULL
published	NULL
procedures	NULL
.	NULL

For	NULL
Hela	NULL
cells	NULL
those	NULL
activities	NULL
were	NULL
determined	NULL
36-48	NULL
h	NULL
posttransfection	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
to	NULL
the	NULL
B-galactosidase	NULL
levels	NULL
provided	NULL
by	NULL
the	NULL
cotransfected	NULL
internal	NULL
standard	NULL
vector	NULL
Reported	NULL
data	NULL
represented	NULL
the	NULL
mean	NULL
from	NULL
several	NULL
independent	NULL
experiments	NULL
.	NULL

Deletion	NULL
Constructs	NULL
of	NULL
the	NULL
CD36	NULL
Promoter	NULL
Region-An	NULL
EcoRI-Pstl	NULL
fragment	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
that	NULL
contains	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
approximately	NULL
2.8	NULL
kilobase	NULL
pairs	NULL
upstream	NULL
from	NULL
it	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
CD36	NULL
genomic	NULL
phage	NULL
ACh2IACD36.1	NULL
(	NULL
described	NULL
by	NULL
Armesilla	NULL
and	NULL
Vega	NULL
(	NULL
1994	NULL
)	NULL
)	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
ligated	NULL
to	NULL
a	NULL
pair	NULL
of	NULL
partially	NULL
complementary	NULL
oligonucleotides	NULL
-	NULL
(	NULL
GTGTAGGACTTTCCTGCA	NULL
and	NULL
AGCTTGCAG-GAAAGTCCTACACTGCA	NULL
,	NULL
derived	NULL
from	NULL
the	NULL
promoter	NULL
region	NULL
+11/+28	NULL
and	NULL
displaying	NULL
Psfl	NULL
and	NULL
HindIII	NULL
sites	NULL
when	NULL
annealed	NULL
)	NULL
,	NULL
and	NULL
to	NULL
EcoRI-Hindlll-digested	NULL
vector	NULL
pUCBM21	NULL
.	NULL

Fragment	NULL
EcoRI-Hindlll	NULL
was	NULL
blunt-ended	NULL
with	NULL
Klenow	NULL
and	NULL
subcloned	NULL
into	NULL
the	NULL
blunt-ended	NULL
Bg/II	NULL
site	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
pGL2-Basic	NULL
(	NULL
Promega	NULL
)	NULL
to	NULL
yield	NULL
the	NULL
plasmid	NULL
p2.8KbCD36-lue	NULL
,	NULL
which	NULL
included	NULL
-2.8	NULL
kilobase	NULL
pairs	NULL
to	NULL
+28	NULL
bp	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
region	NULL
.	NULL

Plasmid	NULL
p2.8KbCD36-lue	NULL
was	NULL
used	NULL
as	NULL
the	NULL
starting	NULL
material	NULL
to	NULL
generate	NULL
the	NULL
progressive	NULL
5	NULL
'	NULL
end	NULL
deletion	NULL
constructs	NULL
p2.5KbCD36-lue	NULL
to	NULL
pO.6KbCD36-lue	NULL
using	NULL
the	NULL
Erase	NULL
a	NULL
Base	NULL
kit	NULL
(	NULL
Pro-mega	NULL
)	NULL
.	NULL

Plasmids	NULL
of	NULL
the	NULL
series	NULL
p2.8KbCD36-luc	NULL
to	NULL
p0.6KbCD36-lue	NULL
contained	NULL
the	NULL
CD36	NULL
promoter	NULL
region	NULL
comprised	NULL
between	NULL
nucleotides	NULL
-X	NULL
and	NULL
+28	NULL
.	NULL

Plasmids	NULL
p267CD36-lue	NULL
to	NULL
p38CD36-luec	NULL
were	NULL
generated	NULL
by	NULL
PCR	NULL
using	NULL
the	NULL
DNA	NULL
isolated	NULL
from	NULL
phage	NULL
ACh21ACD36.1	NULL
as	NULL
template	NULL
and	NULL
pairs	NULL
of	NULL
oligonucleotides	NULL
containing	NULL
sites	NULL
for	NULL
restriction	NULL
enzymes	NULL
Kpn	NULL
!	NULL

and	NULL
Xhol	NULL
.	NULL

The	NULL
resulting	NULL
PCR	NULL
fragments	NULL
were	NULL
ligated	NULL
to	NULL
Kpnl-Xhol-digested	NULL
vector	NULL
pGL2-Basic	NULL
.	NULL

The	NULL
structure	NULL
of	NULL
all	NULL
of	NULL
the	NULL
PCR-generated	NULL
constructs	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Plasmids	NULL
of	NULL
the	NULL
series	NULL
p267CD36-lue	NULL
to	NULL
p38CD36-luc	NULL
contained	NULL
the	NULL
CD36	NULL
promoter	NULL
region	NULL
comprised	NULL
between	NULL
nucleotides	NULL
-X	NULL
and	NULL
+43	NULL
.	NULL

Site-directed	NULL
Mutagenesis-Mutation	NULL
in	NULL
the	NULL
PEBP2	NULL
site	NULL
at	NULL
position	NULL
-103	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
was	NULL
performed	NULL
by	NULL
polymerase	NULL
chain	NULL
reac-tion	NULL
.	NULL

Plasmid	NULL
p158CD36-lue	NULL
was	NULL
used	NULL
as	NULL
a	NULL
template	NULL
.	NULL

Primer	NULL
A	NULL
(	NULL
GTT-	NULL
*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
PEBP2/CBF	NULL
,	NULL
polyomavirus	NULL
enhancer-binding	NULL
protein	NULL
2/core-binding	NULL
factor	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PCR	NULL
,	NULL
polymerase	NULL
chain	NULL
reaction	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
.	NULL

GGTACCTCAGTAATGTGCTGTGT	NULL
)	NULL
and	NULL
primer	NULL
B	NULL
(	NULL
GCGAAGCTTTT-GTTGCCAGAGGAATTGAAAG	NULL
)	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
fragment	NULL
1	NULL
.	NULL

Primers	NULL
C	NULL
(	NULL
GCGAAGCTTCACTGGGATCTGACACTGTAG	NULL
)	NULL
and	NULL
D	NULL
(	NULL
GGTCTCGAGGATCAAATGGTATTCTGCAGG	NULL
)	NULL
were	NULL
used	NULL
to	NULL
generate	NULL
fragment	NULL
2	NULL
.	NULL

Primers	NULL
B	NULL
and	NULL
C	NULL
were	NULL
partially	NULL
complementary	NULL
and	NULL
carried	NULL
the	NULL
point	NULL
mutations	NULL
for	NULL
the	NULL
PEBP2	NULL
site	NULL
.	NULL

PCR	NULL
fragment	NULL
1	NULL
was	NULL
digested	NULL
with	NULL
KpnI	NULL
and	NULL
HindIII	NULL
.	NULL

PCR	NULL
fragment	NULL
2	NULL
was	NULL
digested	NULL
with	NULL
HindIII	NULL
and	NULL
Xhol	NULL
.	NULL

Both	NULL
digested	NULL
fragments	NULL
were	NULL
ligated	NULL
to	NULL
KprnI-Xhol	NULL
vector	NULL
pGL2-Basic	NULL
to	NULL
generate	NULL
the	NULL
pCD36-158	NULL
{	NULL
(	NULL
m-102/-98	NULL
)	NULL
-lue	NULL
plasmid	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
mutant	NULL
was	NULL
confirmed	NULL
by	NULL
DNA	NULL
sequencing	NULL
.	NULL

Nuclear	NULL
Extracts	NULL
and	NULL
EMSA-Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
,	NULL
with	NULL
the	NULL
inclusion	NULL
of	NULL
the	NULL
phospha-tase	NULL
inhibitor	NULL
sodium	NULL
orthovanadate	NULL
at	NULL
10	NULL
mM	NULL
,	NULL
the	NULL
protease	NULL
inhibitors	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
at	NULL
1	NULL
ug/pl	NULL
,	NULL
and	NULL
phenylmethylsulfo-nyl	NULL
fluoride	NULL
at	NULL
2	NULL
mM	NULL
.	NULL

For	NULL
EMSA	NULL
experiments	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
``	NULL
°P-labeled	NULL
using	NULL
avian	NULL
myeloblastosis	NULL
virus	NULL
reverse	NULL
transcriptase	NULL
.	NULL

0.5	NULL
ng	NULL
of	NULL
probe	NULL
at	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
about	NULL
10°	NULL
epm/ug	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
4	NULL
°C	NULL
with	NULL
2-6	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
in	NULL
20	NULL
pl	NULL
containing	NULL
28	NULL
mM	NULL
EDTA	NULL
,	NULL
15	NULL
mm	NULL
KCl	NULL
,	NULL
6	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
7	NULL
mm	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
at	NULL
4	NULL
°C	NULL
)	NULL
,	NULL
7	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
2.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
acety-lated	NULL
DNase-free	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

For	NULL
competition	NULL
assays	NULL
,	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
at	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
15	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radiolabeled	NULL
probe	NULL
.	NULL

When	NULL
required	NULL
,	NULL
antibodies	NULL
were	NULL
added	NULL
to	NULL
the	NULL
nuclear	NULL
extracts	NULL
15	NULL
min	NULL
prior	NULL
to	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
radioactive	NULL
probe	NULL
.	NULL

Two	NULL
pl	NULL
and	NULL
1	NULL
pl	NULL
of	NULL
the	NULL
antibodies	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
R3034	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
N.	NULL
A.	NULL
Speck	NULL
)	NULL
were	NULL
used	NULL
,	NULL
respectively	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
electrophoresed	NULL
at	NULL
15	NULL
V/em	NULL
on	NULL
4-5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
in	NULL
0.4	NULL
x	NULL
TBE	NULL
(	NULL
45	NULL
mm	NULL
Tris	NULL
base	NULL
,	NULL
45	NULL
mM	NULL
borie	NULL
acid	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
XAR	NULL
film	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotides	NULL
used	NULL
for	NULL
EMSA	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
.	NULL

RESULTS	NULL
A	NULL
158-bp	NULL
Fragment	NULL
from	NULL
the	NULL
5	NULL
)	NULL
Region	NULL
of	NULL
the	NULL
CD36	NULL
Gene	NULL
Controls	NULL
Gene	NULL
Expression	NULL
in	NULL
Monocytic	NULL
Cell	NULL
Lines-The	NULL
involvement	NULL
of	NULL
CD36	NULL
expressed	NULL
on	NULL
monocyte/macrophage	NULL
cells	NULL
in	NULL
atherosclerosis	NULL
development	NULL
and	NULL
phagocytosis	NULL
of	NULL
apoptotic	NULL
cells	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

As	NULL
cell	NULL
models	NULL
we	NULL
have	NULL
used	NULL
the	NULL
widely	NULL
characterized	NULL
monocytic	NULL
cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
THP-1	NULL
(	NULL
Ziegler-Heitbrock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Liibbert	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

All	NULL
of	NULL
them	NULL
displayed	NULL
CD36	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
as	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
fluoresceinated	NULL
CD36-specific	NULL
antibodies	NULL
.	NULL
``	NULL

By	NULL
contrast	NULL
,	NULL
Jurkat	NULL
,	NULL
K562	NULL
,	NULL
and	NULL
Hela	NULL
cells	NULL
were	NULL
used	NULL
as	NULL
nonex-pressing	NULL
CD36	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
CD36-specific	NULL
cell	NULL
surface	NULL
staining	NULL
and	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL
``	NULL

To	NULL
examine	NULL
the	NULL
promoter	NULL
activity	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
and	NULL
to	NULL
identify	NULL
potential	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
essential	NULL
for	NULL
its	NULL
constitutive	NULL
transcriptional	NULL
activity	NULL
,	NULL
a	NULL
series	NULL
of	NULL
deletion	NULL
fragments	NULL
of	NULL
the	NULL
region	NULL
5'-upstream	NULL
from	NULL
the	NULL
TATA	NULL
box	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
(	NULL
in	NULL
the	NULL
range	NULL
from	NULL
-2.8	NULL
kilobase	NULL
pairs	NULL
to	NULL
-38	NULL
bp	NULL
)	NULL
was	NULL
generated	NULL
and	NULL
coupled	NULL
to	NULL
the	NULL
luciferase	NULL
reporter	NULL
vector	NULL
pGL2-Basic	NULL
.	NULL

Plasmids	NULL
were	NULL
transfected	NULL
in	NULL
several	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
the	NULL
luciferase	NULL
activity	NULL
directed	NULL
by	NULL
each	NULL
construct	NULL
was	NULL
measured	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

CD36	NULL
deletion	NULL
promoter	NULL
constructs	NULL
yielded	NULL
between	NULL
40-	NULL
and	NULL
80-fold	NULL
higher	NULL
luciferase	NULL
activities	NULL
than	NULL
the	NULL
pGL2-Basic	NULL
promoterless	NULL
construct	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
,	NULL
while	NULL
they	NULL
only	NULL
reached	NULL
a	NULL
maximum	NULL
of	NULL
14	NULL
times	NULL
in	NULL
Jurkat	NULL
and	NULL
K562	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
B	NULL
and	NULL
D	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
1	NULL
)	NULL
the	NULL
5'-upstream	NULL
region	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
possesses	NULL
promoter	NULL
activity	NULL
and	NULL
2	NULL
)	NULL
the	NULL
reporter	NULL
luciferase	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
is	NULL
more	NULL
efficiently	NULL
transcribed	NULL
in	NULL
the	NULL
CD36-expressing	NULL
monocytic	NULL
cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
than	NULL
in	NULL
the	NULL
non-CD36-expressing	NULL
cell	NULL
lines	NULL
Jurkat	NULL
and	NULL
K562	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
promoter	NULL
activities	NULL
of	NULL
the	NULL
CD36	NULL
constructs	NULL
in	NULL
Mono	NULL
*A.	NULL
L.	NULL
Armesilla	NULL
,	NULL
D.	NULL
Calvo	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
Vega	NULL
,	NULL
unpublished	NULL
observations	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
7788	NULL
A	NULL
Mono	NULL
Mac	NULL
6	NULL
pGL2-Basic	NULL
pGL2-Promoter	NULL
p2.8KbCD36-luc	NULL
p2.5KbCD36-luc	NULL
p1.7KbCD36-luc	NULL
p1.3KbCD36-luc	NULL
p0.9KbCD36-luc	NULL
p0.6KbCD36-luc	NULL
p267CD36-luc	NULL
p225CD36-luc	NULL
p193CD36-luc	NULL
p158CD36-luc	NULL
p90CD36-Juc	NULL
p38CD36-fuc	NULL
|	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
_	NULL
100	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
above	NULL
background	NULL
)	NULL
U937	NULL
pGL2-Basic	NULL
|	NULL
pGL2-Promoter	NULL
p267CD36-lue	NULL
p225CD36-luc	NULL
p193CD36-luc	NULL
p158CD36-luc	NULL
pS0CD36-luc	NULL
p38CD36-luc	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
100	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
above	NULL
background	NULL
)	NULL
B	NULL
Jurkat	NULL
pGL2-Basic	NULL
|	NULL
p158CD36-luc	NULL
pS0CD36-luc	NULL
p38CD36-lue	NULL
0	NULL
20	NULL
40	NULL
60	NULL
so	NULL
_	NULL
100	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
above	NULL
background	NULL
)	NULL
K562	NULL
pGL2-Basic	NULL
pGL2-Promoter	NULL
p267CD36-luc	NULL
p225CD36-luc	NULL
p193CD36-uc	NULL
p158CD36-luc	NULL
p90CD36-luc	NULL
p38CD36-luc	NULL
|	NULL
0	NULL
20	NULL
40	NULL
60	NULL
80	NULL
100	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
above	NULL
background	NULL
)	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
CD36	NULL
promoter	NULL
.	NULL

A	NULL
panel	NULL
of	NULL
CD36	NULL
promoter	NULL
deletion	NULL
constructs	NULL
coupled	NULL
to	NULL
the	NULL
reported	NULL
luciferase	NULL
gene	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
the	NULL
cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
U937	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
K562	NULL
,	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Promoter	NULL
activity	NULL
of	NULL
each	NULL
construct	NULL
was	NULL
expressed	NULL
as	NULL
-fold	NULL
activity	NULL
above	NULL
the	NULL
background	NULL
activity	NULL
conferred	NULL
by	NULL
the	NULL
promoterless	NULL
control	NULL
plasmid	NULL
pGL2-Basic	NULL
,	NULL
corrected	NULL
for	NULL
transfection	NULL
efficiency	NULL
(	NULL
Bottinger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Number	NULL
enclosed	NULL
in	NULL
parenthesis	NULL
in	NULL
charts	NULL
B	NULL
and	NULL
D	NULL
denote	NULL
the	NULL
relative	NULL
luciferase	NULL
activities	NULL
yielded	NULL
by	NULL
the	NULL
pGL2-promoter	NULL
construct	NULL
(	NULL
which	NULL
contains	NULL
the	NULL
SV40	NULL
promoter	NULL
)	NULL
.	NULL

Mac	NULL
6	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
higher	NULL
than	NULL
or	NULL
comparable	NULL
with	NULL
the	NULL
activity	NULL
directed	NULL
by	NULL
vector	NULL
pGL2-Promoter	NULL
(	NULL
Promega	NULL
)	NULL
(	NULL
which	NULL
contains	NULL
the	NULL
SV40	NULL
promoter	NULL
)	NULL
,	NULL
while	NULL
they	NULL
were	NULL
significantly	NULL
lower	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
Jurkat	NULL
and	NULL
K562	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A-D	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
indicate	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
correlates	NULL
with	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
CD36	NULL
and	NULL
suggests	NULL
that	NULL
the	NULL
promoter	NULL
contains	NULL
regulatory	NULL
elements	NULL
that	NULL
contribute	NULL
to	NULL
the	NULL
tissue-specific	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
comparable	NULL
luciferase	NULL
activities	NULL
were	NULL
obtained	NULL
after	NULL
transfection	NULL
of	NULL
constructs	NULL
having	NULL
5	NULL
'	NULL
ends	NULL
ranging	NULL
from	NULL
-2.8	NULL
kilobase	NULL
pairs	NULL
to	NULL
-158	NULL
bp	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
cells	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
region	NULL
-158/+43	NULL
retains	NULL
most	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Data	NULL
obtained	NULL
with	NULL
U937	NULL
cells	NULL
further	NULL
supported	NULL
this	NULL
finding	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL
``	NULL

Nevertheless	NULL
,	NULL
our	NULL
experiments	NULL
did	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
other	NULL
regions	NULL
located	NULL
upstream	NULL
from	NULL
position	NULL
-158	NULL
may	NULL
play	NULL
important	NULL
positive	NULL
or	NULL
negative	NULL
regulatory	NULL
roles	NULL
,	NULL
which	NULL
might	NULL
have	NULL
remained	NULL
hidden	NULL
by	NULL
mutual	NULL
compensatory	NULL
effects	NULL
.	NULL

A	NULL
further	NULL
deletion	NULL
extending	NULL
to	NULL
-90	NULL
bp	NULL
resulted	NULL
in	NULL
a	NULL
70	NULL
%	NULL
reduction	NULL
of	NULL
the	NULL
basal	NULL
promoter	NULL
activity	NULL
in	NULL
both	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
dropping	NULL
the	NULL
activity	NULL
to	NULL
the	NULL
levels	NULL
found	NULL
out	NULL
in	NULL
the	NULL
CD36-negative	NULL
cell	NULL
lines	NULL
Jurkat	NULL
and	NULL
K562	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A-D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
point	NULL
out	NULL
the	NULL
presence	NULL
of	NULL
strong	NULL
positive	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
region	NULL
-158/-90	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
the	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Deletion	NULL
to	NULL
-38	NULL
bp	NULL
(	NULL
a	NULL
construct	NULL
that	NULL
still	NULL
preserved	NULL
an	NULL
intact	NULL
TATA	NULL
box	NULL
)	NULL
abrogated	NULL
promoter	NULL
activity	NULL
,	NULL
indicating	NULL
the	NULL
presence	NULL
of	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
region	NULL
-90/-38	NULL
necessary	NULL
for	NULL
the	NULL
basal	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

The	NULL
Region	NULL
Comprising	NULL
the	NULL
Nucleotides	NULL
-102/-98	NULL
Is	NULL
Required	NULL
for	NULL
Optimal	NULL
Transcription	NULL
of	NULL
the	NULL
CD36	NULL
Gene-A	NULL
search	NULL
within	NULL
the	NULL
-158/-90	NULL
region	NULL
for	NULL
nucleotide	NULL
sequences	NULL
corresponding	NULL
to	NULL
binding	NULL
sites	NULL
for	NULL
known	NULL
transcription	NULL
factors	NULL
revealed	NULL
the	NULL
sequence	NULL
ACCACA	NULL
at	NULL
position	NULL
-103	NULL
,	NULL
which	NULL
con	NULL
forms	NULL
to	NULL
the	NULL
core	NULL
site	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
PEBP2/CBF	NULL
family	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Ogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
,	NULL
also	NULL
referred	NULL
as	NULL
the	NULL
AML1	NULL
family	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
functional	NULL
significance	NULL
of	NULL
the	NULL
putative	NULL
PEBP2	NULL
site	NULL
,	NULL
the	NULL
core	NULL
PEBP2	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
pCD36-158-lue	NULL
construct	NULL
was	NULL
mutated	NULL
from	NULL
ACCACA	NULL
to	NULL
AAGCTT	NULL
(	NULL
originating	NULL
the	NULL
construct	NULL
pCD36-158	NULL
(	NULL
m-102/-98	NULL
)	NULL
-luc	NULL
)	NULL
.	NULL

When	NULL
these	NULL
constructs	NULL
were	NULL
transfected	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
cells	NULL
,	NULL
the	NULL
promoter	NULL
activity	NULL
directed	NULL
by	NULL
the	NULL
mutant	NULL
construct	NULL
pCD36-158	NULL
(	NULL
m-102/-98	NULL
)	NULL
-lue	NULL
was	NULL
30	NULL
%	NULL
of	NULL
the	NULL
activity	NULL
obtained	NULL
by	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
pCD36-158-luc	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
comparable	NULL
activities	NULL
were	NULL
yielded	NULL
by	NULL
both	NULL
the	NULL
mutant	NULL
and	NULL
wild	NULL
type	NULL
constructs	NULL
in	NULL
Hela	NULL
cells	NULL
,	NULL
an	NULL
observation	NULL
consistent	NULL
with	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
PEBP2/CBEF	NULL
factors	NULL
detected	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
mutant	NULL
also	NULL
decreased	NULL
the	NULL
low	NULL
promoter	NULL
activity	NULL
directed	NULL
by	NULL
the	NULL
wild	NULL
type	NULL
construct	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
PEBP2/CBF	NULL
factors	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
the	NULL
PEBP2/CBEF	NULL
site	NULL
by	NULL
itself	NULL
does	NULL
not	NULL
confer	NULL
the	NULL
tissue	NULL
specificity	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
level	NULL
of	NULL
reduction	NULL
in	NULL
promoter	NULL
activity	NULL
in	NULL
monocytic	NULL
cells	NULL
when	NULL
the	NULL
PEBP2/CBF	NULL
site	NULL
was	NULL
mutated	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
observed	NULL
when	NULL
the	NULL
activity	NULL
directed	NULL
by	NULL
the	NULL
pCD36-90-lue	NULL
construct	NULL
(	NULL
which	NULL
does	NULL
not	NULL
contain	NULL
the	NULL
PEBP2	NULL
site	NULL
)	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
yielded	NULL
by	NULL
the	NULL
pCD36-158-luc	NULL
construct	NULL
(	NULL
which	NULL
does	NULL
contain	NULL
the	NULL
PEBP2	NULL
site	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
region	NULL
-102/-98	NULL
for	NULL
the	NULL
constitutive	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

Transcription	NULL
Factors	NULL
of	NULL
the	NULL
PEBP2	NULL
Family	NULL
Bind	NULL
to	NULL
the	NULL
-102/-98	NULL
Region-To	NULL
investigate	NULL
the	NULL
trans-acting	NULL
factors	NULL
that	NULL
account	NULL
for	NULL
the	NULL
promoter	NULL
activity	NULL
ascribed	NULL
to	NULL
the	NULL
-102/-98	NULL
region	NULL
,	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
-110/	NULL
-91	NULL
region	NULL
and	NULL
comprising	NULL
the	NULL
PEBP2	NULL
core	NULL
sequence	NULL
AC-CACA	NULL
,	NULL
was	NULL
radiolabeled	NULL
and	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
EMSA	NULL
with	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
7784	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
Mono	NULL
Mac	NULL
6	NULL
U937	NULL
EA158wt	NULL
158mut	NULL
HeLa	NULL
Jurkat	NULL
0	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
Relative	NULL
luciferase	NULL
activity	NULL
(	NULL
fold	NULL
above	NULL
background	NULL
)	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Mutation	NULL
of	NULL
site	NULL
-102/-98	NULL
severely	NULL
impairs	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
.	NULL

CD36	NULL
promoter	NULL
wild	NULL
type	NULL
construct	NULL
pCD36-158-luc	NULL
(	NULL
represented	NULL
as	NULL
158w	NULL
?	NULL
)	NULL

and	NULL
mutant	NULL
construct	NULL
pCD36-158	NULL
(	NULL
m-102/-98	NULL
)	NULL
-lue	NULL
(	NULL
represented	NULL
as	NULL
158mut	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
in	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
U937	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
Hela	NULL
cells	NULL
.	NULL

For	NULL
each	NULL
cell	NULL
line	NULL
assayed	NULL
,	NULL
promoter	NULL
activities	NULL
were	NULL
represented	NULL
as	NULL
indicated	NULL
for	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

MM-6	NULL
U937	NULL
THP1	NULL
JY	NULL
Jurkat	NULL
HeLa	NULL
``	NULL
uth	NULL
Probe	NULL
:	NULL
CD36	NULL
(	NULL
-110/-91	NULL
}	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Binding	NULL
of	NULL
CD36	NULL
promoter	NULL
region	NULL
-110/-91	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
several	NULL
cell	NULL
lines	NULL
.	NULL

Radiolabeled	NULL
double-stranded	NULL
CD36	NULL
promoter	NULL
-110/-91	NULL
oligonucleotide	NULL
,	NULL
GCAACAAACCACACACTGGG	NULL
,	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
lines	NULL
of	NULL
different	NULL
origin	NULL
(	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
THP-1	NULL
,	NULL
monocytic	NULL
;	NULL
JY	NULL
,	NULL
B	NULL
lymphoblas-toid	NULL
;	NULL
Jurkat	NULL
,	NULL
T	NULL
cell	NULL
leukemia	NULL
;	NULL
Hela	NULL
,	NULL
epitheloid	NULL
carcinoma	NULL
)	NULL
.	NULL

nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
several	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
the	NULL
monocytic	NULL
cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
6	NULL
,	NULL
U937	NULL
,	NULL
and	NULL
THP-1	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Major	NULL
low	NULL
mobility	NULL
complexes	NULL
were	NULL
observed	NULL
for	NULL
all	NULL
of	NULL
them	NULL
,	NULL
although	NULL
practically	NULL
undetectable	NULL
levels	NULL
were	NULL
found	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
HeLa	NULL
cells	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
complexes	NULL
was	NULL
verified	NULL
by	NULL
competition	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
unlabeled	NULL
oligo-nucleotide	NULL
.	NULL
``	NULL

The	NULL
multiplicity	NULL
,	NULL
distinct	NULL
relative	NULL
mobilities	NULL
,	NULL
and	NULL
wide	NULL
cellular	NULL
distribution	NULL
of	NULL
the	NULL
complexes	NULL
bound	NULL
to	NULL
oligonucleotide	NULL
-110/-91	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
EMSA	NULL
pattern	NULL
for	NULL
transcription	NULL
factors	NULL
of	NULL
the	NULL
PEPB2/CBF	NULL
family	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
,	NULL
1995	NULL
;	NULL
Ogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998b	NULL
;	NULL
Nuchprayoon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
dissimilarity	NULL
between	NULL
the	NULL
retardation	NULL
complexes	NULL
detected	NULL
in	NULL
the	NULL
monocytic	NULL
cell	NULL
lines	NULL
analyzed	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
44	NULL
)	NULL
may	NULL
be	NULL
the	NULL
result	NULL
of	NULL
partial	NULL
proteolytic	NULL
degradation	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
cell	NULL
lines	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
protease	NULL
activity	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
monocytic	NULL
cell	NULL
lines	NULL
,	NULL
making	NULL
isolation	NULL
of	NULL
nuclear	NULL
extracts	NULL
without	NULL
proteolytic	NULL
degradation	NULL
extremely	NULL
difficult	NULL
(	NULL
Galson	NULL
and	NULL
Housman	NULL
,	NULL
1988	NULL
;	NULL
Pahl	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
)	NULL
.	NULL

Particularly	NULL
,	NULL
susceptibility	NULL
to	NULL
proteolytic	NULL
cleavage	NULL
of	NULL
PEBP2/CBF	NULL
factors	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
some	NULL
monocytic	NULL
cell	NULL
lines	NULL
has	NULL
been	NULL
documented	NULL
(	NULL
Nuchprayoon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
relative	NULL
intensities	NULL
of	NULL
the	NULL
complexes	NULL
derived	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
showed	NULL
significant	NULL
variations	NULL
depending	NULL
on	NULL
the	NULL
preparation	NULL
and	NULL
age	NULL
of	NULL
the	NULL
extract	NULL
and	NULL
on	NULL
the	NULL
numbers	NULL
of	NULL
freezing	NULL
and	NULL
thawing	NULL
processes	NULL
undergone	NULL
by	NULL
the	NULL
extract	NULL
.	NULL
``	NULL

For	NULL
the	NULL
above	NULL
reasons	NULL
,	NULL
only	NULL
the	NULL
experiments	NULL
performed	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
are	NULL
shown	NULL
,	NULL
although	NULL
similar	NULL
conclusions	NULL
were	NULL
reached	NULL
when	NULL
nuclear	NULL
extracts	NULL
from	NULL
Mono	NULL
Mac	NULL
6	NULL
and	NULL
U937	NULL
cells	NULL
were	NULL
used	NULL
.	NULL
``	NULL

Binding	NULL
of	NULL
radiolabeled	NULL
oligonucleotide	NULL
-110/-91	NULL
to	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
and	NULL
Jurkat	NULL
cells	NULL
gave	NULL
rise	NULL
to	NULL
several	NULL
complexes	NULL
whose	NULL
formation	NULL
was	NULL
completely	NULL
prevented	NULL
by	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
demonstrating	NULL
their	NULL
specificity	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

An	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
consensus	NULL
core	NULL
for	NULL
the	NULL
PEBP2/CBF	NULL
site	NULL
(	NULL
designated	NULL
as	NULL
AML1	NULL
cons	NULL
.	NULL
)	NULL

and	NULL
derived	NULL
from	NULL
the	NULL
Moloney	NULL
virus	NULL
enhancer	NULL
(	NULL
Wang	NULL
and	NULL
Speck	NULL
,	NULL
1992	NULL
)	NULL
competed	NULL
the	NULL
binding	NULL
of	NULL
all	NULL
complexes	NULL
to	NULL
the	NULL
oligonucleotide	NULL
-110/-91	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
sequence	NULL
ACCACA	NULL
was	NULL
responsible	NULL
for	NULL
the	NULL
appearance	NULL
of	NULL
the	NULL
observed	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
confirmed	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
inhibition	NULL
by	NULL
a	NULL
mutant	NULL
oligonucleotide	NULL
(	NULL
-110/-91	NULL
mut	NULL
)	NULL
,	NULL
which	NULL
spanned	NULL
the	NULL
-110/-91	NULL
region	NULL
and	NULL
contained	NULL
a	NULL
cluster	NULL
of	NULL
mutations	NULL
identical	NULL
to	NULL
those	NULL
generated	NULL
in	NULL
the	NULL
mutant	NULL
construct	NULL
pCD36-158	NULL
(	NULL
m-102/-98	NULL
)	NULL
-lue	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
decrease	NULL
of	NULL
transcriptional	NULL
activity	NULL
in	NULL
this	NULL
mutant	NULL
is	NULL
due	NULL
to	NULL
the	NULL
loss	NULL
of	NULL
its	NULL
capability	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
factors	NULL
bound	NULL
to	NULL
the	NULL
PEBP2/CBEF	NULL
site	NULL
(	NULL
nucleotides	NULL
-103/-98	NULL
)	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
complexes	NULL
observed	NULL
,	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
THP-1	NULL
and	NULL
Jurkat	NULL
were	NULL
independently	NULL
incubated	NULL
with	NULL
two	NULL
distinct	NULL
antibodies	NULL
specific	NULL
for	NULL
AML1	NULL
factors	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
the	NULL
labeled	NULL
oligonucleotide	NULL
-110/-91	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
the	NULL
«	NULL
-AML1	NULL
antisera	NULL
,	NULL
raised	NULL
against	NULL
the	NULL
N-terminal	NULL
region	NULL
of	NULL
the	NULL
AML1	NULL
a	NULL
subunit	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
,	NULL
induced	NULL
specific	NULL
supershift	NULL
in	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
as	NULL
negative	NULL
control	NULL
see	NULL
last	NULL
lane	NULL
showing	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
probe	NULL
to	NULL
the	NULL
antibody	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
by	NULL
several	NULL
investigators	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Nuchprayoon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
rabbit	NULL
polyclonal	NULL
antibody	NULL
R3034	NULL
raised	NULL
against	NULL
the	NULL
DNA-binding	NULL
domain	NULL
of	NULL
AML1	NULL
,	NULL
but	NULL
not	NULL
a	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
,	NULL
prevented	NULL
the	NULL
formation	NULL
of	NULL
most	NULL
of	NULL
the	NULL
complexes	NULL
.	NULL

Given	NULL
the	NULL
high	NULL
degree	NULL
of	NULL
amino	NULL
acid	NULL
sequence	NULL
similarity	NULL
within	NULL
the	NULL
regions	NULL
used	NULL
to	NULL
generate	NULL
both	NULL
the	NULL
«	NULL
-AML1	NULL
and	NULL
the	NULL
R3034	NULL
antisera	NULL
,	NULL
between	NULL
the	NULL
different	NULL
members	NULL
constituting	NULL
the	NULL
PEBP2Z/CBF	NULL
family	NULL
,	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
both	NULL
antisera	NULL
react	NULL
with	NULL
several	NULL
members	NULL
of	NULL
the	NULL
PEBP2/CBEF	NULL
transcription	NULL
family	NULL
(	NULL
Levanon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
similar	NULL
set	NULL
of	NULL
experiments	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
extracts	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
PEBP2/CBEF	NULL
transcription	NULL
factors	NULL
present	NULL
in	NULL
monocytes	NULL
bind	NULL
in	NULL
vitro	NULL
to	NULL
the	NULL
CD36	NULL
promoter	NULL
,	NULL
therefore	NULL
allowing	NULL
us	NULL
to	NULL
extend	NULL
the	NULL
conclusions	NULL
to	NULL
normal	NULL
(	NULL
nontransformed	NULL
)	NULL
monocytes	NULL
.	NULL

Altogether	NULL
,	NULL
these	NULL
findings	NULL
demonstrate	NULL
that	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
PEBP2/CBF	NULL
family	NULL
bind	NULL
to	NULL
the	NULL
region	NULL
-103/	NULL
-98	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
and	NULL
regulate	NULL
its	NULL
functional	NULL
activity	NULL
DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Deletion	NULL
analysis	NULL
has	NULL
revealed	NULL
1	NULL
)	NULL
that	NULL
the	NULL
CD36	NULL
promoter	NULL
contributes	NULL
to	NULL
its	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
7785	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

CD36	NULL
promoter	NULL
contains	NULL
a	NULL
A	NULL
PEBP2/CBEF	NULL
site	NULL
at	NULL
region	NULL
-103/-98	NULL
.	NULL

A	NULL
,	NULL
radiolabeled	NULL
double-stranded	NULL
CD36	NULL
promoter	NULL
-110/-91	NULL
oligonucleotide	NULL
was	NULL
-	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
THP-1	NULL
and	NULL
Jurkat	NULL
.	NULL

Prior	NULL
to	NULL
adding	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
following	NULL
cold	NULL
double-stranded	NULL
oligonucleotides	NULL
:	NULL
-110/-91	NULL
,	NULL
to	NULL
A	NULL
Co	NULL
%	NULL
Jurkat	NULL
&	NULL
*	NULL
-C	NULL
A	NULL
A	NULL
s	NULL
-110/-91	NULL
R3034	NULL
R3034	NULL
c-AML1	NULL
AML1	NULL
cons	NULL
.	NULL

I	NULL
AML1	NULL
cons	NULL
.	NULL

-110/-91	NULL
mut	NULL
-110/-91	NULL
110/91	NULL
-110/-91	NULL
mut	NULL
demonstrate	NULL
specificity	NULL
of	NULL
complexes	NULL
;	NULL
-110/-91	NULL
_	NULL
mut	NULL
-	NULL
(	NULL
GCAACAAAAGCT-TCACTGGG	NULL
)	NULL
,	NULL
to	NULL
assay	NULL
the	NULL
effect	NULL
of	NULL
positions	NULL
-102/-98	NULL
in	NULL
the	NULL
binding	NULL
;	NULL
and	NULL
AML1	NULL
cons	NULL
.	NULL

(	NULL
GGATATCTGTGGTAAGCA	NULL
)	NULL
,	NULL
an	NULL
oligonucletide	NULL
containing	NULL
a	NULL
PEBP2Z/CBF	NULL
consensus	NULL
site	NULL
from	NULL
the	NULL
Moloney	NULL
murine	NULL
leukemia	NULL
virus	NULL
enhancer	NULL
,	NULL
to	NULL
assay	NULL
the	NULL
molecular	NULL
nature	NULL
of	NULL
the	NULL
complexes	NULL
bound	NULL
to	NULL
oligonucleotide	NULL
-110/-91	NULL
.	NULL

-	NULL
,	NULL
no	NULL
inhibitor	NULL
added	NULL
.	NULL

B	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
cell	NULL
lines	NULL
THP-1	NULL
and	NULL
Jurkat	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
double-stranded	NULL
oligonucleotide	NULL
-110/-91	NULL
,	NULL
without	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
a	NULL
prior	NULL
incubation	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
oligonucleotide	NULL
-110/-91	NULL
,	NULL
rabbit	NULL
preimmune	NULL
sera	NULL
(	NULL
PZ	NULL
)	NULL
,	NULL
or	NULL
AML1-specific	NULL
antisera	NULL
e-AML1	NULL
or	NULL
R3034	NULL
.	NULL

The	NULL
last	NULL
lane	NULL
shows	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
antisera	NULL
a-AML1	NULL
on	NULL
the	NULL
labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
-110/-91	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
nuclear	NULL
extract	NULL
.	NULL

*	NULL
4	NULL
AML1	NULL
cons	NULL
.	NULL

62	NULL
,	NULL
PI	NULL
-110/-91	NULL
mut	NULL
R3034	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
contain	NULL
PEBP2/CBF	NULL
factors	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
CD36	NULL
promoter	NULL
PEBP2/	NULL
CBF	NULL
site	NULL
.	NULL

Radiolabeled	NULL
double-stranded	NULL
CD36	NULL
promoter	NULL
-110/-91	NULL
oligonucleotide	NULL
was	NULL
incubated	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
THP-1	NULL
cells	NULL
and	NULL
from	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Prior	NULL
to	NULL
adding	NULL
the	NULL
radiolabeled	NULL
oligonucleotide	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
cold	NULL
double-stranded	NULL
oligonucleotides	NULL
-110/	NULL
-91	NULL
,	NULL
-110/-91	NULL
mut	NULL
,	NULL
and	NULL
AML1	NULL
cons	NULL
.	NULL

(	NULL
see	NULL
Fig	NULL
.	NULL

4	NULL
legend	NULL
for	NULL
details	NULL
)	NULL
or	NULL
with	NULL
rabbit	NULL
preimmune	NULL
sera	NULL
(	NULL
PF	NULL
)	NULL
or	NULL
AML1-specific	NULL
antisera	NULL
R8084	NULL
.	NULL

-	NULL
,	NULL
no	NULL
inhibitor	NULL
added	NULL
.	NULL

monocytic-specific	NULL
expression	NULL
,	NULL
and	NULL
2	NULL
)	NULL
that	NULL
most	NULL
of	NULL
the	NULL
promoter	NULL
activity	NULL
is	NULL
contained	NULL
within	NULL
the	NULL
-158/+43	NULL
region	NULL
,	NULL
which	NULL
encompasses	NULL
the	NULL
subregion	NULL
-158/-90	NULL
required	NULL
for	NULL
the	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
also	NULL
shown	NULL
that	NULL
within	NULL
the	NULL
above	NULL
region	NULL
members	NULL
of	NULL
the	NULL
PEBP2/	NULL
CBF	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
bind	NULL
to	NULL
nucleotides	NULL
-103/	NULL
-98	NULL
.	NULL

Moreover	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
PEBP2	NULL
site	NULL
severely	NULL
impaired	NULL
H.	NULL
``	NULL
tug	NULL
_	NULL
bug	NULL
(	NULL
Din	NULL
\	NULL
k	NULL
y	NULL
``	NULL
``	NULL
Probe	NULL
:	NULL
CD36	NULL
(	NULL
-110/-91	NULL
)	NULL
Probe	NULL
:	NULL
CD36	NULL
(	NULL
-110/-91	NULL
)	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
CD36	NULL
promoter	NULL
,	NULL
outlining	NULL
the	NULL
significant	NULL
contribution	NULL
of	NULL
the	NULL
PEBP2/	NULL
CBF	NULL
site	NULL
to	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

PEBP2/CBEF	NULL
are	NULL
heterodimeric	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

They	NULL
were	NULL
initially	NULL
identified	NULL
as	NULL
factors	NULL
interacting	NULL
with	NULL
the	NULL
polyomavirus	NULL
enhancer	NULL
core	NULL
site	NULL
(	NULL
Wang	NULL
and	NULL
Speck	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

They	NULL
are	NULL
constituted	NULL
by	NULL
an	NULL
a	NULL
subunit	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
DNA	NULL
consensus	NULL
sequence	NULL
ACCACA	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
harbors	NULL
a	NULL
transactivation	NULL
domain	NULL
,	NULL
and	NULL
a	NULL
B	NULL
subunit	NULL
,	NULL
which	NULL
enhances	NULL
the	NULL
DNA-binding	NULL
affinity	NULL
of	NULL
the	NULL
a	NULL
subunit	NULL
through	NULL
heterodimer	NULL
formation	NULL
(	NULL
Ogawa	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1998a	NULL
;	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

While	NULL
the	NULL
B	NULL
subunit	NULL
is	NULL
encoded	NULL
by	NULL
a	NULL
single	NULL
gene	NULL
,	NULL
the	NULL
a	NULL
subunits	NULL
are	NULL
encoded	NULL
by	NULL
three	NULL
genes	NULL
,	NULL
designated	NULL
as	NULL
PEBP2	NULL
«	NULL
A	NULL
,	NULL
PEBP2	NULL
«	NULL
B	NULL
,	NULL
and	NULL
PEBP2	NULL
«	NULL
C	NULL
in	NULL
mouse	NULL
and	NULL
AML3	NULL
,	NULL
AML1	NULL
,	NULL
and	NULL
AML2	NULL
in	NULL
human	NULL
,	NULL
respectively	NULL
(	NULL
Bae	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
1995	NULL
;	NULL
Levanon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
a	NULL
subunits	NULL
share	NULL
a	NULL
128-amino	NULL
acid	NULL
region	NULL
known	NULL
as	NULL
the	NULL
runt	NULL
domain	NULL
,	NULL
first	NULL
found	NULL
(	NULL
and	NULL
hence	NULL
its	NULL
name	NULL
)	NULL
in	NULL
the	NULL
Drosophila	NULL
melanogaster	NULL
segmentation	NULL
gene	NULL
,	NULL
runt	NULL
(	NULL
Kania	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Kagoshima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
heterodimerization	NULL
(	NULL
Ogawa	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

Alternatively	NULL
spliced	NULL
forms	NULL
for	NULL
the	NULL
a	NULL
subunits	NULL
(	NULL
Ogawa	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
,	NULL
Bae	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
,	NULL
Levanon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
the	NULL
B	NULL
subunit	NULL
(	NULL
Ogawa	NULL
et	NULL
al	NULL
.	NULL

1993a	NULL
,	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
have	NULL
been	NULL
described	NULL
.	NULL

The	NULL
relevance	NULL
in	NULL
gene	NULL
regulation	NULL
of	NULL
the	NULL
different	NULL
protein	NULL
forms	NULL
is	NULL
at	NULL
present	NULL
unknown	NULL
(	NULL
Bae	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
cellular	NULL
distribution	NULL
,	NULL
one	NULL
should	NULL
expect	NULL
to	NULL
find	NULL
transcripts	NULL
corresponding	NULL
to	NULL
all	NULL
of	NULL
the	NULL
three	NULL
AML	NULL
a	NULL
subunits	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
(	NULL
Levanon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
identification	NULL
of	NULL
the	NULL
«	NULL
subunits	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
the	NULL
CD36	NULL
promoter	NULL
must	NULL
await	NULL
generation	NULL
of	NULL
specific	NULL
reagents	NULL
for	NULL
each	NULL
subunit	NULL
.	NULL

So	NULL
far	NULL
,	NULL
only	NULL
a	NULL
few	NULL
genes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
PEBP2/CBEF	NULL
transcription	NULL
factors	NULL
.	NULL

Gene	NULL
expression	NULL
of	NULL
the	NULL
myeloid	NULL
genes	NULL
encoding	NULL
murine	NULL
neutrophil	NULL
elastase	NULL
,	NULL
myeloper-oxidase	NULL
(	NULL
Suzow	NULL
and	NULL
Friedman	NULL
,	NULL
1993	NULL
;	NULL
Nuchprayoon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
and	NULL
human	NULL
colony-stimulating	NULL
factor	NULL
receptor	NULL
(	NULL
Zhang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
is	NULL
controlled	NULL
by	NULL
PEBP2/CBEF	NULL
transcription	NULL
factors	NULL
.	NULL

Functional	NULL
sites	NULL
for	NULL
PEBP2/CBF	NULL
factors	NULL
have	NULL
been	NULL
also	NULL
described	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
(	NULL
Gottschalk	NULL
and	NULL
Leiden	NULL
,	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
7786	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
1990	NULL
;	NULL
Redondo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
in	NULL
the	NULL
enhancers	NULL
of	NULL
murine	NULL
leukemia	NULL
viruses	NULL
(	NULL
Wang	NULL
and	NULL
Speck	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Like	NULL
the	NULL
murine	NULL
myeloid	NULL
genes	NULL
neutrophil	NULL
elastase	NULL
,	NULL
my-eloperoxidase	NULL
(	NULL
Nuchprayoon	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
(	NULL
Giese	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
trans-activation	NULL
experiments	NULL
carried	NULL
out	NULL
in	NULL
Hela	NULL
cells	NULL
with	NULL
vector	NULL
pEF-BOSaB1	NULL
(	NULL
which	NULL
drives	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
B	NULL
chain	NULL
)	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
pCD36-158-lue	NULL
construct	NULL
,	NULL
``	NULL
suggesting	NULL
the	NULL
requirement	NULL
of	NULL
other	NULL
factors	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
by	NULL
PEBP2/CBEF	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
reconstitution	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
enhancer	NULL
activity	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
required	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
stereospecific	NULL
complex	NULL
constituted	NULL
by	NULL
the	NULL
transcription	NULL
factors	NULL
PEBP2/CBF	NULL
,	NULL
Ets-1	NULL
,	NULL
and	NULL
the	NULL
lymphoid-specific	NULL
high-mobility	NULL
group	NULL
protein	NULL
LEF-1	NULL
(	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

That	NULL
the	NULL
mutation	NULL
of	NULL
the	NULL
PEBP2	NULL
site	NULL
abolished	NULL
most	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
does	NULL
not	NULL
imply	NULL
that	NULL
other	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
might	NULL
not	NULL
be	NULL
required	NULL
for	NULL
efficient	NULL
transcription	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
.	NULL

Transcription	NULL
factors	NULL
Ets-1	NULL
,	NULL
Ets-2	NULL
(	NULL
Wot-ton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
and	NULL
Myb	NULL
(	NULL
Herngndez-Munain	NULL
and	NULL
Krangel	NULL
,	NULL
1994	NULL
,	NULL
1995	NULL
)	NULL
are	NULL
known	NULL
to	NULL
synergize	NULL
with	NULL
PEBP2/CBF	NULL
factors	NULL
.	NULL

Meyer	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
,	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
functional	NULL
studies	NULL
of	NULL
PEBP2/CBEF	NULL
sites	NULL
in	NULL
several	NULL
promoters	NULL
,	NULL
have	NULL
outlined	NULL
the	NULL
conclusion	NULL
that	NULL
the	NULL
PEBP2/CBF	NULL
factors	NULL
are	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
tissue-specific	NULL
activity	NULL
.	NULL

Our	NULL
data	NULL
on	NULL
the	NULL
PEBP2/	NULL
CBF	NULL
site	NULL
in	NULL
the	NULL
CD36	NULL
promoter	NULL
support	NULL
this	NULL
statement	NULL
.	NULL

The	NULL
human	NULL
AML1	NULL
gene	NULL
is	NULL
involved	NULL
in	NULL
translocations	NULL
t	NULL
(	NULL
8	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q22	NULL
;	NULL
q22	NULL
)	NULL
and	NULL
t	NULL
(	NULL
3	NULL
;	NULL
21	NULL
)	NULL
(	NULL
q26	NULL
,	NULL
q422	NULL
)	NULL
(	NULL
reviewed	NULL
by	NULL
Nucifora	NULL
and	NULL
Rowley	NULL
(	NULL
1995	NULL
)	NULL
)	NULL
and	NULL
accounts	NULL
for	NULL
12	NULL
%	NULL
of	NULL
all	NULL
forms	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
Miyoshi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
human	NULL
PEBP2/CBEF	NULL
B	NULL
gene	NULL
undergoes	NULL
an	NULL
inversion	NULL
(	NULL
inv	NULL
(	NULL
16	NULL
)	NULL
(	NULL
p13q422	NULL
)	NULL
)	NULL
,	NULL
also	NULL
associated	NULL
with	NULL
a	NULL
particular	NULL
subtype	NULL
of	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
Liu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
short	NULL
transcript	NULL
form	NULL
of	NULL
AML1	NULL
(	NULL
designated	NULL
as	NULL
AML1a	NULL
)	NULL
,	NULL
which	NULL
lacks	NULL
the	NULL
transactivation	NULL
domain	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
fusion	NULL
proteins	NULL
resulting	NULL
as	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
translocations	NULL
dominantly	NULL
suppress	NULL
transcriptional	NULL
activation	NULL
by	NULL
presumably	NULL
interfering	NULL
with	NULL
binding	NULL
of	NULL
transactivat-ing	NULL
PEBP2/CBF	NULL
forms	NULL
(	NULL
Meyers	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Through	NULL
this	NULL
mechanism	NULL
the	NULL
PEBP2/CBF	NULL
forms	NULL
lacking	NULL
transactivation	NULL
capacity	NULL
inhibit	NULL
myeloid	NULL
differentiation	NULL
and	NULL
may	NULL
cause	NULL
leukemia	NULL
(	NULL
Tanaka	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
studies	NULL
highlight	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
AML1	NULL
gene	NULL
in	NULL
myeloid	NULL
cell	NULL
growth	NULL
and/or	NULL
differen-tiation	NULL
,	NULL
and	NULL
strengthen	NULL
its	NULL
proposed	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
CD36	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

Little	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
factors	NULL
and	NULL
molecular	NULL
events	NULL
that	NULL
regulate	NULL
the	NULL
expression	NULL
and	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
PEBP2/CBEF	NULL
genes	NULL
.	NULL

Dr.	NULL
Ito	NULL
and	NULL
co-workers	NULL
(	NULL
Lu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
have	NULL
recently	NULL
discovered	NULL
that	NULL
the	NULL
B	NULL
subunit	NULL
of	NULL
PEBP2/CBEF	NULL
is	NULL
mainly	NULL
found	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
from	NULL
where	NULL
it	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
a	NULL
chain	NULL
,	NULL
thus	NULL
increasing	NULL
binding	NULL
affinity	NULL
of	NULL
the	NULL
«	NULL
subunit	NULL
for	NULL
the	NULL
DNA	NULL
.	NULL

Molecular	NULL
events	NULL
that	NULL
dictate	NULL
such	NULL
a	NULL
unique	NULL
regulatory	NULL
mechansim	NULL
are	NULL
so	NULL
far	NULL
un-known	NULL
,	NULL
but	NULL
they	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
crucial	NULL
in	NULL
regulating	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
PEBP2	NULL
transcription	NULL
factors	NULL
,	NULL
and	NULL
the	NULL
genes	NULL
under	NULL
their	NULL
control	NULL
.	NULL

It	NULL
would	NULL
therefore	NULL
be	NULL
rational	NULL
to	NULL
investigate	NULL
whether	NULL
changes	NULL
in	NULL
the	NULL
expression	NULL
and	NULL
in	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
PEBP2	NULL
factors	NULL
occur	NULL
under	NULL
conditions	NULL
that	NULL
modulate	NULL
the	NULL
RNA	NULL
expression	NULL
levels	NULL
of	NULL
CD36	NULL
,	NULL
such	NULL
as	NULL
interaction	NULL
of	NULL
monocytes	NULL
with	NULL
E-selectin	NULL
,	NULL
interleukin-4	NULL
,	NULL
lipopo-lysaccharide	NULL
,	NULL
and	NULL
y-interferon	NULL
(	NULL
Huh	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
high	NULL
levels	NULL
of	NULL
CD36	NULL
expression	NULL
found	NULL
in	NULL
immature	NULL
erythrocytes	NULL
(	NULL
Edelman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
may	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
PEBP2/CBEF	NULL
«	NULL
B	NULL
chain	NULL
detected	NULL
in	NULL
this	NULL
type	NULL
of	NULL
cells	NULL
(	NULL
Satake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
CD36	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
different	NULL
tissues	NULL
makes	NULL
conceivable	NULL
the	NULL
existence	NULL
of	NULL
distinct	NULL
regulatory	NULL
mechanisms	NULL
on	NULL
each	NULL
tissue	NULL
type	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
,	NULL
expression	NULL
of	NULL
CD36	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
although	NULL
so	NULL
far	NULL
not	NULL
detected	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
dependent	NULL
on	NULL
the	NULL
transcription	NULL
factor	NULL
Oct-2	NULL
(	NULL
Konig	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
a	NULL
factor	NULL
not	NULL
found	NULL
in	NULL
all	NULL
cell	NULL
types	NULL
where	NULL
CD36	NULL
is	NULL
expressed	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
analyzing	NULL
the	NULL
transcription	NULL
factors	NULL
governing	NULL
the	NULL
basal	NULL
promoter	NULL
activity	NULL
found	NULL
downstream	NULL
from	NULL
position	NULL
-90	NULL
.	NULL

Preliminary	NULL
experiments	NULL
indicate	NULL
that	NULL
a	NULL
Spl	NULL
site	NULL
close	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
could	NULL
possibly	NULL
account	NULL
for	NULL
this	NULL
activity	NULL
.	NULL

The	NULL
characterization	NULL
of	NULL
the	NULL
CD36	NULL
gene	NULL
promoter	NULL
provided	NULL
in	NULL
this	NULL
report	NULL
establishes	NULL
the	NULL
molecular	NULL
basis	NULL
to	NULL
further	NULL
dissect	NULL
the	NULL
promoter	NULL
in	NULL
activating	NULL
conditions	NULL
,	NULL
such	NULL
as	NULL
those	NULL
existing	NULL
in	NULL
the	NULL
microenvironments	NULL
where	NULL
monocytes	NULL
are	NULL
found	NULL
when	NULL
participating	NULL
in	NULL
foam	NULL
cell	NULL
formation	NULL
and	NULL
clearance	NULL
of	NULL
apoptotic	NULL
cells	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
Scott	NULL
Hiebert	NULL
for	NULL
providing	NULL
the	NULL
c-AML1	NULL
serum	NULL
,	NULL
Dr.	NULL
Nancy	NULL
A..	NULL
Speck	NULL
for	NULL
providing	NULL
the	NULL
antisera	NULL
to	NULL
the	NULL
runt	NULL
domain	NULL
of	NULL
AML1	NULL
,	NULL
Dr.	NULL
Yoshiaki	NULL
Ito	NULL
and	NULL
Dr.	NULL
Shigekazy	NULL
Nagata	NULL
for	NULL
providing	NULL
the	NULL
expression	NULL
plasmids	NULL
pEF-BOS	NULL
and	NULL
pEF-BOSaB1	NULL
,	NULL
and	NULL
Dr.	NULL
Angel	NULL
L.	NULL
Corbi	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
Abumrad	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
El-Maghrabi	NULL
,	NULL
R.	NULL
,	NULL
Arri	NULL
,	NULL
E.	NULL
,	NULL
Lépez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Grimaldi	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
17665-17668	NULL
Acton	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Scherer	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
Lodish	NULL
,	NULL
H.	NULL
F.	NULL
,	NULL
and	NULL
Krieger	NULL
,	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
21003-21009	NULL
Armesilla	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
and	NULL
Vega	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
18985-18991	NULL
Asch	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Barnwell	NULL
,	NULL
J.	NULL
,	NULL
Silverstein	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Nachman	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

79	NULL
,	NULL
1054-1061	NULL
Asch	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Liu	NULL
,	NULL
I.	NULL
,	NULL
Briccetti	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Barnwell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Kwakye-Berko	NULL
,	NULL
F.	NULL
,	NULL
Dokun	NULL
,	NULL
A.	NULL
,	NULL
Goldberger	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Pernambuco	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1486-1440	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Oka	NULL
,	NULL
H.	NULL
,	NULL
Masanobu	NULL
,	NULL
S.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Debra	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
3242-3252	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Takahashi	NULL
,	NULL
E.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
W.	NULL
,	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
Jenkins	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Gilbert	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Copeland	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Gene	NULL
(	NULL
Amst	NULL
.	NULL
)	NULL

,	NULL
in	NULL
press	NULL
Barnwell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Ockenhouse	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
and	NULL
Knowles	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1985	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

185	NULL
,	NULL
3494-3497	NULL
Béttinger	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Shelley	NULL
,	NULL
C.	NULL
S.	NULL
,	NULL
Farokhzad	NULL
,	NULL
O.	NULL
C.	NULL
,	NULL
and	NULL
Arnaut	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2604-2615	NULL
Calvo	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Vega	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
18929-18985	NULL
Calvo	NULL
,	NULL
D.	NULL
,	NULL
Dopazo	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Vega	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Genomics	NULL
25	NULL
,	NULL
100-106	NULL
Clezardin	NULL
,	NULL
P.	NULL
,	NULL
McGregor	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Dechvanne	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Clemetson	NULL
,	NULL
K.	NULL
J	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

60	NULL
,	NULL
331-838	NULL
Edelman	NULL
,	NULL
P.	NULL
,	NULL
Vinci	NULL
,	NULL
G.	NULL
Villeval	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Henri	NULL
,	NULL
A.	NULL
,	NULL
Miglierina	NULL
,	NULL
R.	NULL
,	NULL
Rouger	NULL
,	NULL
P.	NULL
,	NULL
Reviron	NULL
,	NULL
J.	NULL
,	NULL
Breton-Gorius	NULL
,	NULL
J.	NULL
,	NULL
Sureau	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Edelman	NULL
,	NULL
L.	NULL
(	NULL
1986	NULL
)	NULL
Blood	NULL
67	NULL
,	NULL
56-63	NULL
Endemann	NULL
,	NULL
G.	NULL
,	NULL
Stanton	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
Madden	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Bryant	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
White	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
and	NULL
Protter	NULL
,	NULL
A	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
11811-11816	NULL
Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
and	NULL
Housman	NULL
,	NULL
D.	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
381-892	NULL
Giese	NULL
,	NULL
K.	NULL
,	NULL
Kingley	NULL
,	NULL
C.	NULL
,	NULL
Kirshner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Grosschedl	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
995-1008	NULL
Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
Leiden	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1990	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10	NULL
,	NULL
5486-5495	NULL
Greenwalt	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Lipsky	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
Ockenhouse	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Ikeda	NULL
,	NULL
H.	NULL
,	NULL
Tandon	NULL
,	NULL
N.	NULL
N.	NULL
,	NULL
and	NULL
Jamieson	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
1105-1115	NULL
Greenwalt	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Scheck	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
and	NULL
Rhinehart-Jones	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

96	NULL
,	NULL
1382-1388	NULL
Hernandez-Munain	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
473-483	NULL
C.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3090-3099	NULL
Huh	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Lo	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Yesner	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Silverstein	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
6267-6271	NULL
Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Ohki	NULL
,	NULL
M.	NULL
,	NULL
Pepling	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gergen	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

9	NULL
,	NULL
338-341	NULL
Kania	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Bonner	NULL
A.	NULL
S.	NULL
,	NULL
Duffy	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Gergen	NULL
J.	NULL
P.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1701-1703	NULL
Kieffer	NULL
,	NULL
N.	NULL
,	NULL
Bettaieb	NULL
,	NULL
A.	NULL
,	NULL
Legrand	NULL
,	NULL
C.	NULL
,	NULL
Coulombel	NULL
,	NULL
L.	NULL
,	NULL
Vainchenker	NULL
,	NULL
W.	NULL
,	NULL
Edelman	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Breton-Gorius	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

262	NULL
,	NULL
835-842	NULL
Kénig	NULL
,	NULL
H.	NULL
,	NULL
Pfisterer	NULL
,	NULL
P.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Wirth	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
&	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1598-1607	NULL
Krieger	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Herz	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

68	NULL
,	NULL
601-637	NULL
Levanon	NULL
,	NULL
D.	NULL
,	NULL
Negreanu	NULL
,	NULL
V.	NULL
,	NULL
Bernstein	NULL
,	NULL
Y.	NULL
,	NULL
Bar-Am	NULL
,	NULL
I.	NULL
,	NULL
Avivi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Groner	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genomics	NULL
28	NULL
,	NULL
425-432	NULL
Liu	NULL
,	NULL
P.	NULL
,	NULL
Tarlé	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Hajra	NULL
,	NULL
A.	NULL
,	NULL
Claxton	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
Marlton	NULL
,	NULL
P.	NULL
,	NULL
Freddman	NULL
,	NULL
M.	NULL
,	NULL
Siciliano	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Collins	NULL
,	NULL
F.	NULL
S.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1041-1044	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Bae	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1651-1661	NULL
Liibbert	NULL
,	NULL
M.	NULL
,	NULL
Herrmann	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
Koeffler	NULL
,	NULL
H.	NULL
P.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
909-924	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Downing	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
6336-6345	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Lenny	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1974-1982	NULL
Miyoshi	NULL
,	NULL
H.	NULL
,	NULL
Kozu	NULL
,	NULL
T.	NULL
,	NULL
Shimizu	NULL
,	NULL
K.	NULL
,	NULL
Enomoto	NULL
,	NULL
K.	NULL
,	NULL
Maseki	NULL
,	NULL
N.	NULL
,	NULL
Kaneko	NULL
,	NULL
Y.	NULL
,	NULL
Kamada	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Ohki	NULL
,	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
2715-2721	NULL
Nicholson	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Frieda	NULL
,	NULL
S.	NULL
,	NULL
Pearce	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Silverstein	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1995	NULL
)	NULL
Arterioscler	NULL
.	NULL

Thromb	NULL
.	NULL

Vasc	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
269-275	NULL
Nuchprayoon	NULL
I.	NULL
,	NULL
Meyers	NULL
,	NULL
S.	NULL
,	NULL
Scott	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Suzow	NULL
,	NULL
J.	NULL
,	NULL
Hiebert	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A	NULL
.	NULL

610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
7787	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
5558-5568	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Rowley	NULL
,	NULL
J.	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
86	NULL
,	NULL
1-14	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Inuzuka	NULL
,	NULL
M.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Naito-Fujimoto	NULL
,	NULL
M.	NULL
,	NULL
Ito	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Shigesada	NULL
,	NULL
K.	NULL
(	NULL
19932	NULL
)	NULL
Virology	NULL
194	NULL
,	NULL
314-331	NULL
Ogawa	NULL
,	NULL
E.	NULL
,	NULL
Maruyama	NULL
,	NULL
M.	NULL
,	NULL
Kagoshima	NULL
,	NULL
H.	NULL
,	NULL
Inuzuka	NULL
,	NULL
I.	NULL
,	NULL
Lu	NULL
,	NULL
J.	NULL
,	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Shigesada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Ito	NULL
.	NULL

,	NULL
Y	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
6859-6863	NULL
Oquendo	NULL
,	NULL
P.	NULL
,	NULL
Hundt	NULL
,	NULL
E.	NULL
,	NULL
Lawler	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Seed	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
58	NULL
,	NULL
95-101	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Burn	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1991	NULL
)	NULL
Exp	NULL
.	NULL

Hematol	NULL
.	NULL

19	NULL
,	NULL
1038-1041	NULL
Pahl	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
Scheibe	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Galson	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Maki	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
5014-5020	NULL
Redondo	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Pfohl	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Herngndez-Munain	NULL
,	NULL
C.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Krangel	NULL
,	NULL
M.	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
4817-4823	NULL
Ren	NULL
,	NULL
Y.	NULL
,	NULL
Silverstein	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Allen	NULL
J.	NULL
,	NULL
and	NULL
Savill	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181	NULL
,	NULL
1857-1862	NULL
Rigotti	NULL
,	NULL
A.	NULL
,	NULL
Acton	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Krieger	NULL
,	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
16221-16224	NULL
Satake	NULL
,	NULL
M.	NULL
,	NULL
Nomura	NULL
,	NULL
S.	NULL
,	NULL
Yamaguchi-Iwai	NULL
,	NULL
Y.	NULL
,	NULL
Takahama	NULL
,	NULL
Y.	NULL
,	NULL
Hashimoto	NULL
,	NULL
Y.	NULL
,	NULL
Niki	NULL
,	NULL
M.	NULL
,	NULL
Kitamura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Ito	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
1662-1670	NULL
Savill	NULL
,	NULL
J.	NULL
,	NULL
Hogg	NULL
,	NULL
N.	NULL
,	NULL
Ren	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Haslett	NULL
,	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

90	NULL
,	NULL
1518-1522	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
Matthias	NULL
,	NULL
P.	NULL
,	NULL
Muller	NULL
,	NULL
M.	NULL
M.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
6419	NULL
Silverstein	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Baird	NULL
,	NULL
M.	NULL
,	NULL
Lo	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
and	NULL
Yesner	NULL
,	NULL
L.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
16607-16612	NULL
Suzow	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Friedman	NULL
,	NULL
A.	NULL
D.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
2141-2151	NULL
Swerlick	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Lee	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Wick	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
and	NULL
Lawley	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
78-83	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Tanaka	NULL
,	NULL
K.	NULL
,	NULL
Ogawa	NULL
,	NULL
S.	NULL
,	NULL
Kurokawa	NULL
,	NULL
M.	NULL
,	NULL
Mitani	NULL
,	NULL
K.	NULL
,	NULL
Nishida	NULL
,	NULL
J.	NULL
,	NULL
Shibata	NULL
,	NULL
Y.	NULL
,	NULL
Yazaki	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Hirai	NULL
,	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
341-350	NULL
Tandon	NULL
,	NULL
N.	NULL
N.	NULL
,	NULL
Kralisz	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Jamieson	NULL
,	NULL
G.	NULL
A	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
7576-7583	NULL
van	NULL
Schravendijk	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Handunnetti	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Barnwell	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
2105-2114	NULL
Vega	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Segui-Real	NULL
,	NULL
B.	NULL
,	NULL
Garcia	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Calés	NULL
,	NULL
C.	NULL
,	NULL
Rodriguez	NULL
,	NULL
F.	NULL
,	NULL
Vanderkerck-hove	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Sandoval	NULL
,	NULL
I.	NULL
V.	NULL
(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
16818-16824	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
89-102	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Wang	NULL
,	NULL
Q.	NULL
,	NULL
Crute	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Melnikova	NULL
,	NULL
I.	NULL
N.	NULL
,	NULL
Keller	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
and	NULL
Speck	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
3324-3339	NULL
Wotton	NULL
,	NULL
D.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
S.	NULL
,	NULL
Speck	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
and	NULL
Owen	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
840-850	NULL
Zhang	NULL
,	NULL
D.	NULL
E.	NULL
,	NULL
Fujioka	NULL
,	NULL
K.	NULL
I.	NULL
,	NULL
Hetherrington	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Shapiro	NULL
,	NULL
L.	NULL
H.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
Look	NULL
A.	NULL
T.	NULL
,	NULL
and	NULL
Tenen	NULL
,	NULL
D.	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
8085-8095	NULL
Ziegler-Heitbrock	NULL
,	NULL
H.	NULL
W.	NULL
L.	NULL
,	NULL
Thiel	NULL
,	NULL
E.	NULL
,	NULL
Fiitterer	NULL
,	NULL
A.	NULL
,	NULL
Herzog	NULL
,	NULL
V.	NULL
,	NULL
Wirtz	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Riethmiiller	NULL
,	NULL
G.	NULL
(	NULL
1988	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
41	NULL
,	NULL
456-461	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
Aq	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL
Structural	NULL
and	NULL
Functional	NULL
Characterization	NULL
of	NULL
the	NULL
Human	NULL
CD36	NULL
Gene	NULL
Promoter	NULL
:	NULL
IDENTIFICATION	NULL
OF	NULL
A	NULL
PROXIMAL	NULL
PEBP2/CBF	NULL
SITE	NULL
Angel	NULL
L.	NULL
Armesilla	NULL
,	NULL
Dominica	NULL
Calvo	NULL
and	NULL
Miguel	NULL
A.	NULL
Vega	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1996	NULL
,	NULL
271:7781-7787.	NULL
doi	NULL
:	NULL
10.1074/jb0.271.13.7781	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/271/13/7781	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
59	NULL
references	NULL
,	NULL
44	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
3/7781	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
uo	NULL
1son	NULL
$	NULL
4q	NULL
/S10°0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wrojr	NULL
popeopumog	NULL

